| Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ... PloS one 4 (3), e4724, 2009 | 967 | 2009 |
| Human T-lymphotropic virus 1: recent knowledge about an ancient infection K Verdonck, E González, S Van Dooren, AM Vandamme, G Vanham, ... The Lancet infectious diseases 7 (4), 266-281, 2007 | 667 | 2007 |
| Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ... The Journal of infectious diseases 192 (6), 958-966, 2005 | 540 | 2005 |
| An automated genotyping system for analysis of HIV-1 and other microbial sequences T De Oliveira, K Deforche, S Cassol, M Salminen, D Paraskevis, ... Bioinformatics 21 (19), 3797-3800, 2005 | 537 | 2005 |
| Tracing the origin and history of the HIV-2 epidemic P Lemey, OG Pybus, B Wang, NK Saksena, M Salemi, AM Vandamme Proceedings of the National Academy of Sciences 100 (11), 6588-6592, 2003 | 534 | 2003 |
| The phylogenetic handbook: a practical approach to phylogenetic analysis and hypothesis testing P Lemey, M Salemi, AM Vandamme Cambridge University Press, 2009 | 449 | 2009 |
| Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration R Kantor, DA Katzenstein, B Efron, AP Carvalho, B Wynhoven, P Cane, ... PLoS Med 2 (4), e112, 2005 | 365 | 2005 |
| Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event L Vijgen, E Keyaerts, E Moës, I Thoelen, E Wollants, P Lemey, ... Journal of virology 79 (3), 1595-1604, 2005 | 357 | 2005 |
| European guidelines on the clinical management of HIV-1 tropism testing LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vézinet, B Clotet, ... The Lancet infectious diseases 11 (5), 394-407, 2011 | 288 | 2011 |
| Transmission of drug-resistant HIV-1 is stabilizing in Europe J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ... The Journal of infectious diseases 200 (10), 1503-1508, 2009 | 283 | 2009 |
| Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools AC Pineda-Peña, NR Faria, S Imbrechts, P Libin, AB Abecasis, ... Infection, genetics and evolution 19, 337-348, 2013 | 248 | 2013 |
| 2', 5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'', 2''-oxathiole-2'', 2'-dioxide) pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human … J Balzarini, MJ Perez-Perez, A San-Felix, D Schols, CF Perno, ... Proceedings of the National Academy of Sciences 89 (10), 4392-4396, 1992 | 237 | 1992 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS Med 12 (4), e1001810, 2015 | 231 | 2015 |
| Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase. R Pauwels, K Andries, Z Debyser, P Van Daele, D Schols, P Stoffels, ... Proceedings of the National Academy of Sciences 90 (5), 1711-1715, 1993 | 223 | 1993 |
| phylogenetic handbook M Salemi, AM Vandamme Cambridge University Press, 2003 | 210 | 2003 |
| DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A L Coelmont, X Hanoulle, U Chatterji, C Berger, J Snoeck, M Bobardt, ... PloS one 5 (10), e13687, 2010 | 200 | 2010 |
| HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase J Balzarini, A Karlsson, MJ Perez-Perez, L Vrang, J Walbers, H Zhang, ... Virology 192 (1), 246-253, 1993 | 191 | 1993 |
| Updated European recommendations for the clinical use of HIV drug resistance testing AM Vandamme, A Sönnerborg, M Ait-Khaled, J Albert, B Asjo, L Bacheler, ... Antiviral therapy 9 (6), 829-848, 2004 | 187 | 2004 |
| Dating the common ancestor of SIVcpz and HIV‐1 group M and the origin of HIV‐1 subtypes by using a new method to uncover clock‐like molecular evolution M Salemi, K Strimmer, WW Hall, M Duffy, E Delaporte, S Mboup, ... The FASEB Journal 15 (2), 276-278, 2001 | 185 | 2001 |
| A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients K Van Laethem, A De Luca, A Antinori, A Cingolani, CF Perna, ... Antiviral therapy 7 (2), 123-9, 2002 | 175 | 2002 |
